|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online November 3, 2003
doi: 10.1242/10.1242/dev.00820

1 Genetics of Development and Disease Branch, NIDDK, NIH, 10/9N105, 10 Center
Drive, Bethesda, MD 20892, USA
3 Laboratory of Genetics and Physiology, NIDDK, NIH, 10/9N105, 10 Center Drive,
Bethesda, MD 20892, USA
2 Department of Surgery, Neuroscience Program, Upstate Medical University,
Syracuse, NY 13210, USA
Author for correspondence (e-mail:
chuxiad{at}bdg10.niddk.nih.gov)
Accepted 27 August 2003
Smad4 is a central mediator for TGFß signals, which play important functions in many biological processes. To study the role of Smad4 in mammary gland development and neoplasia, we disrupted this gene in mammary epithelium using a Cre-loxP approach. Smad4 is expressed in the mammary gland throughout development; however, its inactivation did not cause abnormal development of the gland during the first three pregnancies. Instead, lack of Smad4 gradually induced cell proliferation, alveolar hyperplasia and transdifferentiation of mammary epithelial cells into squamous epithelial cells. Consequently, all mutant mice developed squamous cell carcinoma and/or mammary abscesses between 5 and 16 months of age. We demonstrated that absence of Smad4 resulted in ß-catenin accumulation at onset and throughout the process of transdifferentiation, implicating ß-catenin, a key component of the Wnt signaling pathway, in the development of squamous metaplasia in Smad4-null mammary glands. We further demonstrated that TGFß1 treatment degraded ß-catenin and induced epithelial-mesenchymal transformation in cultured mammary epithelial cells. However, such actions were blocked in the absence of Smad4. These findings indicate that TGFß/Smad4 signals play a role in cell fate maintenance during mammary gland development and neoplasia.
Key words: Smad4/Dpc4, TGFß, Transdifferentiation, Keratinocytes, Neoplasia
This article has been cited by other articles:
![]() |
S. Zhao, K. Venkatasubbarao, J. W. Lazor, J. Sperry, C. Jin, L. Cao, and J. W. Freeman Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor {beta}-Mediated Invasion and Metastasis in Pancreatic Cancer Cells Cancer Res., June 1, 2008; 68(11): 4221 - 4228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y.C. Chow, K. T. Quach, B. L. Cabrera, J. A. Cabral, S. E. Beck, and J. M. Carethers RAS/ERK modulates TGF{beta}-regulated PTEN expression in human pancreatic adenocarcinoma cells Carcinogenesis, November 1, 2007; 28(11): 2321 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, Y. Xie, S. Zhang, V. Dusevich, L.F. Bonewald, and J.Q. Feng DMP1-targeted Cre Expression in Odontoblasts and Osteocytes J. Dent. Res., April 1, 2007; 86(4): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bardeesy, K.-h. Cheng, J. H. Berger, G. C. Chu, J. Pahler, P. Olson, A. F. Hezel, J. Horner, G. Y. Lauwers, D. Hanahan, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes & Dev., November 15, 2006; 20(22): 3130 - 3146. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Zhao and F. M. Hoffmann Inhibition of Transforming Growth Factor-beta1-induced Signaling and Epithelial-to-Mesenchymal Transition by the Smad-binding Peptide Aptamer Trx-SARA Mol. Biol. Cell, September 1, 2006; 17(9): 3819 - 3831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gerdes, M. Myakishev, N. A. Frost, V. Rishi, J. Moitra, A. Acharya, M. R. Levy, S.-w. Park, A. Glick, S. H. Yuspa, et al. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res., August 1, 2006; 66(15): 7578 - 7588. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ge, V. Rajeev, P. Ray, E. Lattime, S. Rittling, S. Medicherla, A. Protter, A. Murphy, J. Chakravarty, S. Dugar, et al. Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-{beta} Type I Receptor Kinase In vivo. Clin. Cancer Res., July 15, 2006; 12(14): 4315 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Pangas, X. Li, E. J. Robertson, and M. M. Matzuk Premature Luteinization and Cumulus Cell Defects in Ovarian-Specific Smad4 Knockout Mice Mol. Endocrinol., June 1, 2006; 20(6): 1406 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Serra and M R Crowley Mouse models of transforming growth factor {beta} impact in breast development and cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 749 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levy and C. S. Hill Smad4 Dependency Defines Two Classes of Transforming Growth Factor {beta} (TGF-{beta}) Target Genes and Distinguishes TGF-{beta}-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses Mol. Cell. Biol., September 15, 2005; 25(18): 8108 - 8125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas and C.-H. Heldin Non-Smad TGF-{beta} signals J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B.R. Ewan, H. A. Oketch-Rabah, S. A. Ravani, G. Shyamala, H. L. Moses, and M. H. Barcellos-Hoff Proliferation of Estrogen Receptor-{alpha}-Positive Mammary Epithelial Cells Is Restrained by Transforming Growth Factor-{beta}1 in Adult Mice Am. J. Pathol., August 1, 2005; 167(2): 409 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, L. Wu, D. K. Oelschlager, M. Wan, C. R. Stockard, W. E. Grizzle, N. Wang, H. Chen, Y. Sun, and X. Cao Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor-{alpha}-positive Breast Cancer Cells J. Biol. Chem., July 22, 2005; 280(29): 27022 - 27028. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Coumoul, V. Shukla, C. Li, R.-H. Wang, and C.-X. Deng Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference Nucleic Acids Res., June 24, 2005; 33(11): e102 - e102. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Grady Transforming Growth Factor-{beta}, Smads, and Cancer Clin. Cancer Res., May 1, 2005; 11(9): 3151 - 3154. [Full Text] [PDF] |
||||
![]() |
U. Valcourt, M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas TGF-{beta} and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell Transition Mol. Biol. Cell, April 1, 2005; 16(4): 1987 - 2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Chu, N. R. Dunn, D. C. Anderson, L. Oxburgh, and E. J. Robertson Differential requirements for Smad4 in TGF{beta}-dependent patterning of the early mouse embryo Development, August 1, 2004; 131(15): 3501 - 3512. [Abstract] [Full Text] [PDF] |
||||